One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Heart failure and cardiomyopathies: mechanisms, risk prediction, and new therapeutic targets
doi : 10.1093/eurheartj/ehaf1043
Volume 47, Issue 1, 1 January 2026
William Harvey and the role of the circulation: approaching the quadricentennial
The cardiovascular professional of tomorrow: redefining basic research in the age of artificial intelligence
The EACVI 2025 summit: strengthening networks within cardiovascular imaging
Do obesity and visceral adiposity promote heart failure with reduced ejection fraction?
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association
Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment
Transthyretin amyloid cardiomyopathy: from cause to novel treatments
Incretin-based therapy for heart failure with reduced ejection fraction: why we need a trial
Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trial
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score
Beyond the scar: risk prediction in non-dilated left ventricular cardiomyopathy
Deficiency of the RNA-binding protein RBMS1 improves myocardial fibrosis and heart failure
RNA-binding proteins as therapeutic targets in cardiac fibrosis and heart failure
Bridging The Gaps In EMPEROR-Preserved: Toward safer and smarter use of Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction
Breakthrough outflow tract unlocking: modified transapical balloon-assisted transseptal mitral annuloplasty for high-risk mitral valve-in-ring patients
The great mimicker: aortic extramural haematoma secondary to multi-branch systemic arterial rupture
Weekly Journal Scan: Rethinking dual antiplatelet therapy after coronary artery bypass grafting for acute coronary syndromes
